Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Sunitinib
Polysaccharide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021
Lopinavir
Polysaccharide
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021
Sargassum horneri polysaccharide extract
Polysaccharide
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/15/2021
Enoxaparin
Polysaccharide
Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/12/2021
Tilorone
Polysaccharide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021
Heparin
Polysaccharide
Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/22/2021
Low Molecular Weight Heparin
Polysaccharide
Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/18/2021
Raloxifene
Polysaccharide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020
Hyaluronic acid
Polysaccharide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/12/2020
Acarbose
Polysaccharide
Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/12/2020
6-O-desulfated enoxaparin
Polysaccharide
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/10/2020
6-O-desulfated unfranctionated heparin
Polysaccharide
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/10/2020
Mitoxantrone
Polysaccharide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/04/2020
BNTX
Polysaccharide
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/04/2020